Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 0.50 |
| ▸ | CA1 | P00915 | 14/20 | 0.50 |
| ▸ | CA12 | O43570 | 10/20 | 0.46 |
| ▸ | CA9 | Q16790 | 9/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7914212 | 0.84 | CA2 (0.50) | CA2CA1CA12CA9CA6 | |
| SCHEMBL7911340 | 0.80 | CA2 (0.46) | CA2CA1CA12CA9CA6 | |
| SCHEMBL7917822 | 0.80 | CA2 (0.53) | CA2CA1CA12CA9CA6 | |
| SCHEMBL7158564 | 0.80 | CA2 (0.53) | CA2CA1CA12CA9CA6 | |
| SCHEMBL7911333 | 0.78 | CA2 (0.45) | CA2CA1CA12CA9CA6 | |
| SCHEMBL7911354 | 0.77 | CA2 (0.50) | CA2CA1CA12CA9CA6 | |
| SCHEMBL7913940 | 0.77 | CA1 (0.64) | CA2CA1CA12CA9CA6 | |
| SCHEMBL1805285 | 0.75 | CA2 (0.61) | CA2CA1CA12CA9CA6 | |
| SCHEMBL31670545 | 0.75 | CA1 (0.67) | CA2CA1CA12CA9CA6 | |
| SCHEMBL30230622 | 0.75 | CA2 (0.61) | CA2CA1CA12CA9CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6214882-B1 | Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof | SYNTHELABO (FR) | 2001-04-10 | — | — | US | disclosed |